FDA
- Status: approved
Two different doses of adenosine (Two different doses of adenosine) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
Gødstrup Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.